노상 약물 검사 기기 시장 : 샘플 유형별(타액, 호기, 기타), 물질별(약물, 알코올), 최종사용자별(고속도로경찰, 마약단속국) - 세계 기회 분석 및 산업 예측(2021-2031년)

The roadside drug testing devices market was valued at 421.76 million in 2021, and is projected to reach $707.28 million by 2031 registering a CAGR of 5.3%from 2022 to 2031  

The roadside drug testing refers to looking for traces of drugs in the body using samples of urine, blood, sweat or breath. Passing of drug testing or drug screening tests means that the drug might not be present in the body anymore or presence is in very small amount. This type of roadside drug testing is conducted to ensure safety of the motor vehicle drivers, as influence of drugs and/or alcohol hinders with clear sight and quick mental function. 

Roadside drug testing is often done either by taking sample saliva or breath of the vehicle driver. The device, which is known as breathalyzer, uses deep-lung breath of the tester and thus, detects presence of alcohol in blood. Saliva is more effective at identifying most recent drug usage. However, saliva-based drug testing has the drawback that it is neither Food and Drug Administration approved for use with Department of Telecommunications nor federally mandated drug testing.  

Increase in prevalence of drink and drive all over the globe, propel the growth of the roadside drug testing devices market. For instance, according to a report by the National Institute on Alcohol Abuse and Alcoholism in 2019, 10,142 people lost their lives as a result of drunk driving.  

The roadside drug testing devices market is segmented on the basis of sample type, substance type, and end user. As per sample type, the market is divided into saliva, breath, and others. 

By end user, the market is divided into highway police and drug enforcement agencies. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

• The major companies profiled in the report include, AK GlobalTech Corp., Abbott Laboratories, Drager, Alcohol Countermeasure Systems Corp., Cannabix Technologies Inc., Intelligent Fingerprinting, Lifeloc Technologies, Inc., Oranoxis Inc., Thermo Fisher Scientific, Inc., and UriTox LLC.
• Key Benefits For Stakeholders
• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the roadside drug testing devices market analysis from 2021 to 2031 to identify the prevailing roadside drug testing devices market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the roadside drug testing devices market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global roadside drug testing devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Sample Type

• Saliva
• Breath
• Others

By Substance

• Drugs
• Alcohol

By End User

• Highway Police
• Drug Enforcement Agencies

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • Drager
  • Alcohol Countermeasure Systems Corp.
  • AK GlobalTech Corporation
  • Cannabix Technologies Inc.
  • Intelligent Fingerprinting
  • Lifeloc Technologies, Inc.
  • Oranoxis Inc.
  • Thermo Fisher Scientific, Inc.
  • UriTox LLC.
  • Abbott Laboratories

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Saliva
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market share analysis by country
• 4.3 Breath
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market share analysis by country
• 4.4 Others
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market share analysis by country

CHAPTER 5: ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Drugs
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market share analysis by country
• 5.3 Alcohol
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market share analysis by country

CHAPTER 6: ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Highway Police
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market share analysis by country
• 6.3 Drug Enforcement Agencies
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market share analysis by country

CHAPTER 7: ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Sample Type
  • 7.2.3 North America Market size and forecast, by Substance
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Key market trends, growth factors and opportunities
    • 7.2.5.1.2 Market size and forecast, by Sample Type
    • 7.2.5.1.3 Market size and forecast, by Substance
    • 7.2.5.1.4 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Key market trends, growth factors and opportunities
    • 7.2.5.2.2 Market size and forecast, by Sample Type
    • 7.2.5.2.3 Market size and forecast, by Substance
    • 7.2.5.2.4 Market size and forecast, by End User
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Key market trends, growth factors and opportunities
    • 7.2.5.3.2 Market size and forecast, by Sample Type
    • 7.2.5.3.3 Market size and forecast, by Substance
    • 7.2.5.3.4 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Sample Type
  • 7.3.3 Europe Market size and forecast, by Substance
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Key market trends, growth factors and opportunities
    • 7.3.5.1.2 Market size and forecast, by Sample Type
    • 7.3.5.1.3 Market size and forecast, by Substance
    • 7.3.5.1.4 Market size and forecast, by End User
    • 7.3.5.2 France
    • 7.3.5.2.1 Key market trends, growth factors and opportunities
    • 7.3.5.2.2 Market size and forecast, by Sample Type
    • 7.3.5.2.3 Market size and forecast, by Substance
    • 7.3.5.2.4 Market size and forecast, by End User
    • 7.3.5.3 UK
    • 7.3.5.3.1 Key market trends, growth factors and opportunities
    • 7.3.5.3.2 Market size and forecast, by Sample Type
    • 7.3.5.3.3 Market size and forecast, by Substance
    • 7.3.5.3.4 Market size and forecast, by End User
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Key market trends, growth factors and opportunities
    • 7.3.5.4.2 Market size and forecast, by Sample Type
    • 7.3.5.4.3 Market size and forecast, by Substance
    • 7.3.5.4.4 Market size and forecast, by End User
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Key market trends, growth factors and opportunities
    • 7.3.5.5.2 Market size and forecast, by Sample Type
    • 7.3.5.5.3 Market size and forecast, by Substance
    • 7.3.5.5.4 Market size and forecast, by End User
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Key market trends, growth factors and opportunities
    • 7.3.5.6.2 Market size and forecast, by Sample Type
    • 7.3.5.6.3 Market size and forecast, by Substance
    • 7.3.5.6.4 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Sample Type
  • 7.4.3 Asia-Pacific Market size and forecast, by Substance
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 Japan
    • 7.4.5.1.1 Key market trends, growth factors and opportunities
    • 7.4.5.1.2 Market size and forecast, by Sample Type
    • 7.4.5.1.3 Market size and forecast, by Substance
    • 7.4.5.1.4 Market size and forecast, by End User
    • 7.4.5.2 China
    • 7.4.5.2.1 Key market trends, growth factors and opportunities
    • 7.4.5.2.2 Market size and forecast, by Sample Type
    • 7.4.5.2.3 Market size and forecast, by Substance
    • 7.4.5.2.4 Market size and forecast, by End User
    • 7.4.5.3 Australia
    • 7.4.5.3.1 Key market trends, growth factors and opportunities
    • 7.4.5.3.2 Market size and forecast, by Sample Type
    • 7.4.5.3.3 Market size and forecast, by Substance
    • 7.4.5.3.4 Market size and forecast, by End User
    • 7.4.5.4 India
    • 7.4.5.4.1 Key market trends, growth factors and opportunities
    • 7.4.5.4.2 Market size and forecast, by Sample Type
    • 7.4.5.4.3 Market size and forecast, by Substance
    • 7.4.5.4.4 Market size and forecast, by End User
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Key market trends, growth factors and opportunities
    • 7.4.5.5.2 Market size and forecast, by Sample Type
    • 7.4.5.5.3 Market size and forecast, by Substance
    • 7.4.5.5.4 Market size and forecast, by End User
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Key market trends, growth factors and opportunities
    • 7.4.5.6.2 Market size and forecast, by Sample Type
    • 7.4.5.6.3 Market size and forecast, by Substance
    • 7.4.5.6.4 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Sample Type
  • 7.5.3 LAMEA Market size and forecast, by Substance
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Key market trends, growth factors and opportunities
    • 7.5.5.1.2 Market size and forecast, by Sample Type
    • 7.5.5.1.3 Market size and forecast, by Substance
    • 7.5.5.1.4 Market size and forecast, by End User
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Key market trends, growth factors and opportunities
    • 7.5.5.2.2 Market size and forecast, by Sample Type
    • 7.5.5.2.3 Market size and forecast, by Substance
    • 7.5.5.2.4 Market size and forecast, by End User
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Key market trends, growth factors and opportunities
    • 7.5.5.3.2 Market size and forecast, by Sample Type
    • 7.5.5.3.3 Market size and forecast, by Substance
    • 7.5.5.3.4 Market size and forecast, by End User
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Key market trends, growth factors and opportunities
    • 7.5.5.4.2 Market size and forecast, by Sample Type
    • 7.5.5.4.3 Market size and forecast, by Substance
    • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Abbott Laboratories
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 AK GlobalTech Corporation
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 Alcohol Countermeasure Systems Corp.
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 Cannabix Technologies Inc.
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Drager
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Intelligent Fingerprinting
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Lifeloc Technologies, Inc.
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Oranoxis Inc.
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Thermo Fisher Scientific, Inc.
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 UriTox LLC.
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments